Global Equine Supplement Products Market Analysis
According to Verified Market Research, Global Equine Supplement Products Market was valued at USD 73.61 Million in 2018 and is projected to reach USD 96.18 Million by 2026, growing at a CAGR of 3.40 % from 2019 to 2026.
What is Equine Supplement Products?
Equine infectious anemia (EIA) is a retroviral disease of equids that may be characterized by acute and/or chronic recurring clinical signs including fever, anemia. Equine infectious anemia virus occurs in horses and ponies, and has also been reported in mules, enema and cachexia. Animal affected by equines disease is provided with a supplement, that provided to complete something, to make up for a deficiency, or to extend or strengthen the whole.
Global Equine Supplement Products Market Outlook
In the last decade, the prevalence of equines has been an uptick. Equine infectious anemia has been found nearly worldwide. The disease appears to be rare or almost absent in a few countries including Iceland and Japan. During analysis, it has been found that the most common deficiency seen in horses is a lack of adequate calories. Horses often are not given enough feed for the work required of them. Exercise, lactation, and growth all require a lot of calories but talking about supplements, most horse owner and veterinarian people aren't thinking of calories owing to lack of awareness about its importance as a result animal or horses are not taking in enough nutrition to make work their bodies. This led to incidence like an equine disease. Yet, supplemental vitamins or minerals is the only solution that can help with. Initiative programs like "Equine Disease Communication Centre", aims to mitigate the health, welfare, and economic implications of these events for U.S. horses and the industry as a whole, which is predicted to lower the risk of equine disease which in turn will spur the growth of equine supplements product.
Global Equine Supplement Products Market Competitive Landscape
The "Global Equine Supplement Products Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such as Zoetis, Boehringer Ingelheim International GmbH, Bayer AG, Equine Products UK LTD, Purina Animal Nutrition LLC., Vetoquinol S.A., Kentucky Equine Research, Plusvital Limited, Lallemand, Inc., and Virbac. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.
Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.
1. INTRODUCTION OF GLOBAL EQUINE SUPPLEMENT PRODUCTS MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions
2. EXECUTIVE SUMMARY
3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources
4. GLOBAL EQUINE SUPPLEMENT PRODUCTS MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL EQUINE SUPPLEMENT PRODUCTS MARKET, BY SUPPLEMENTS
5.1. Overview
5.2. Proteins
5.3. Vitamins
5.4. Enzymes
5.5. Electrolytes
6. GLOBAL EQUINE SUPPLEMENT PRODUCTS MARKET, BY APPLICATION
6.1. Overview
6.2. Performance Enhancement/Recovery
6.3. Join Disorder Prevention
7. GLOBAL EQUINE SUPPLEMENT PRODUCTS MARKET, BY DISTRIBUTION CHANNEL
7.1. Overview
7.2. Veterinary Hospital Pharmacies
7.3. Retail Pharmacies
8. GLOBAL EQUINE SUPPLEMENT PRODUCTS MARKET, BY GEOGRAPHY
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.2.3. Mexico
8.3. Europe
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Rest of Europe
8.4. Asia Pacific
8.4.1. China
8.4.2. Japan
8.4.3. India
8.4.4. Rest of Asia Pacific
8.5. Rest of the World
9. GLOBAL EQUINE SUPPLEMENT PRODUCTS MARKET COMPETITIVE LANDSCAPE
9.1. Overview
9.2. Company Market Ranking
9.3. Key Development Strategies
10. COMPANY PROFILES
10.1. Zoetis.
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
10.2. Boehringer Ingelheim International GmbH.
10.2.1. Overview
10.2.2. Financial Performance
10.2.3. Product Outlook
10.2.4. Key Developments
10.3. Bayer AG
10.3.1. Overview
10.3.2. Financial Performance
10.3.3. Product Outlook
10.3.4. Key Developments
10.4. Equine Products UK LTD.
10.4.1. Overview
10.4.2. Financial Performance
10.4.3. Product Outlook
10.4.4. Key Developments
10.5. Purina Animal Nutrition LLC
10.5.1. Overview
10.5.2. Financial Performance
10.5.3. Product Outlook
10.5.4. Key Developments
10.6. Vetoquinol S.A.
10.6.1. Overview
10.6.2. Financial Performance
10.6.3. Product Outlook
10.6.4. Key Developments
10.7. Kentucky Equine Research.
10.7.1. Overview
10.7.2. Financial Performance
10.7.3. Product Outlook
10.7.4. Key Developments
10.8. Plusvital Limited
10.8.1. Overview
10.8.2. Financial Performance
10.8.3. Product Outlook
10.8.4. Key Developments
10.9. Lallemand, Inc.
10.9.1. Overview
10.9.2. Financial Performance
10.9.3. Product Outlook
10.9.4. Key Developments
10.10. Virbac.
10.10.1. Overview
10.10.2. Financial Performance
10.10.3. Product Outlook
10.10.4. Key Developments
11. Appendix
11.1. Related Reports